companydata.dkcompanydata.dk

PHARMCO I ApS: Financial statements 2025

CVR: 25204042

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

PHARMCO I ApS (CVR 25204042) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -105,000 and a net result of DKK 92,326,000 compared with DKK 44,804,000 the year before. Equity in the 2025 report amounted to DKK 469,411,000. The solvency ratio was 98.8%. The company had 473 employees in the financial year.

Revenue
DKK 0
Gross Profit
DKK -105,000
Profit/Loss
DKK 92,326,000
Equity
DKK 469,411,000
Total Assets
DKK 475,273,000
Employees
473

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20250-105 t.92.3 mio.469.4 mio.473
20240-98 t.44.8 mio.409.7 mio.440
20230-112 t.32.3 mio.364.6 mio.416
20220-72 t.17.5 mio.332.8 mio.425
20210-69 t.43.2 mio.316.3 mio.420

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is PHARMCO I ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

PHARMCO I ApS: The 2024 annual report is outJun 16, 2025

PHARMCO I ApS has published its annual report for 2024. Revenue came to DKK 0, and the net result was DKK 44,804,000.

About PHARMCO I ApS

PHARMCO I ApS is a Danish company of the type Anpartsselskab based in Vojens, founded in 2000. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Eli Wallin. The company is owned by Eli Wallin. According to the 2025 annual report, the company had an average of 473 employees. In 2025, the company reported a gross profit of DKK -105,000 and a net result of DKK 92,326,000 compared with DKK 44,804,000 the year before. Equity in the 2025 report amounted to DKK 469,411,000.

Source: annual report 2025, Danish Business Authority